A panel of experts stressed the importance of implementing institutional protocols for continuous subcutaneous insulin infusion therapy to ensure the safety of diabetes patients in the hospital setting. The consensus statement, published in the Journal of Diabetes Science and Technology, recommends patients let hospital staff inspect the device and its settings, agree to using the hospital's glucometer for point-of-care glucose testing and consent to changing the infusion site every 48 to 72 hours or as needed.
Experts release guidance on inpatient use of insulin infusion
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.